Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Forms of Multiple Sclerosis”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Post-approval studies (Phase 4)Ended earlyNCT02241785
What this trial is testing

Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 47
Post-approval studies (Phase 4)Study completedNCT02307838
What this trial is testing

Long-term Follow-up of Fingolimod Phase II Study Patients

Who this might be right for
Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT04410991
What this trial is testing

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)

Who this might be right for
Relapsing Multiple Sclerosis
Sanofi 899
Not applicableStudy completedNCT06526000
What this trial is testing

Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated SyndromeRelapsing-remitting Multiple Sclerosis+1 more
Novartis 326
Testing effectiveness (Phase 2)Ended earlyNCT00484536
What this trial is testing

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

Who this might be right for
Multiple Sclerosis
UCB Pharma 232
Large-scale testing (Phase 3)Looking for participantsNCT06141473
What this trial is testing

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 1,600
Large-scale testing (Phase 3)UnknownNCT01464905
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Nuron Biotech Inc. 500
Not applicableStudy completedNCT02519413
What this trial is testing

Tecfidera Lymphocyte Chart Review

Who this might be right for
Multiple Sclerosis
Biogen 483
Large-scale testing (Phase 3)Study completedNCT02980042
What this trial is testing

Safety of Switching From Rituximab to Ocrelizumab in MS Patients

Who this might be right for
Multiple Sclerosis
University of Colorado, Denver 200
Not applicableLooking for participantsNCT06681623
What this trial is testing

A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

Who this might be right for
Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Neurology Center of New England P.C. 20
Not applicableStudy completedNCT01281657
What this trial is testing

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

Who this might be right for
Multiple Sclerosis
Novartis 64
Large-scale testing (Phase 3)Study completedNCT05083923
What this trial is testing

Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 136
Not applicableStudy completedNCT01592097
What this trial is testing

Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

Who this might be right for
Multiple Sclerosis
University of Southern California 51
Not applicableStudy completedNCT01903291
What this trial is testing

Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 333
Large-scale testing (Phase 3)Study completedNCT01199861
What this trial is testing

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis 138
Not applicableStudy completedNCT01070836
What this trial is testing

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 35,895
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Testing effectiveness (Phase 2)Study completedNCT03381170
What this trial is testing

An Extension of the TG1101-RMS201 Trial

Who this might be right for
Relapsing Remitting Multiple Sclerosis
TG Therapeutics, Inc. 48
Not applicableStudy completedNCT01141751
What this trial is testing

An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 334
Early research (Phase 1)Ended earlyNCT01144351
What this trial is testing

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 32
Load More Results